Boston Scientific (Germany) Top Insiders
| BSX Stock | EUR 64.60 0.80 1.25% |
Boston Scientific employs about 53 K people. The company is managed by 17 executives with a total tenure of roughly 123667 years, averaging almost 7274.0 years of service per executive, having 3117.65 employees per reported executive. Examination of Boston Scientific's management performance can provide insight into the company performance.
| Michael Mahoney Chairman President Chairman |
Boston |
Boston Scientific Management Team Effectiveness
The company has return on total asset (ROA) of 0.0576 % which means that it generated a profit of $0.0576 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1268 %, meaning that it generated $0.1268 on every $100 dollars invested by stockholders. Boston Scientific's management efficiency ratios could be used to measure how well Boston Scientific manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Boston Scientific's Return On Tangible Assets are most likely to increase slightly in the upcoming years. The Boston Scientific's current Return On Capital Employed is estimated to increase to 0.18, while Return On Assets are projected to decrease to 0.05. At this time, Boston Scientific's Return On Tangible Assets are most likely to increase slightly in the upcoming years. The Boston Scientific's current Fixed Asset Turnover is estimated to increase to 5.29, while Net Tangible Assets are projected to decrease to (1.6 B).The Boston Scientific's current Net Income Applicable To Common Shares is estimated to increase to about 974.8 M, while Common Stock Shares Outstanding is projected to decrease to roughly 1.6 B. Boston Scientific holds a total of 1.48 Billion outstanding shares. The majority of Boston Scientific outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Boston Scientific to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Boston Scientific. Please pay attention to any change in the institutional holdings of Boston Scientific as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Boston Scientific in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Boston Scientific, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Boston Scientific Workforce Comparison
Boston Scientific is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 54,951. Boston Scientific totals roughly 53,000 in number of employees claiming about 96% of equities under Health Care industry.
Boston Scientific Profit Margins
The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.21 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.21.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.73 | 0.6901 |
|
| |||||
| Operating Profit Margin | 0.2 | 0.1978 |
|
|
Boston Scientific Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Boston Scientific Price Series Summation is a cross summation of Boston Scientific price series and its benchmark/peer.
Boston Scientific Notable Stakeholders
A Boston Scientific stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Boston Scientific often face trade-offs trying to please all of them. Boston Scientific's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Boston Scientific's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Michael Mahoney | President Chairman | Profile | |
| Jonathan Monson | Executive CFO | Profile | |
| Emily Woodworth | Global VP | Profile | |
| Vance JD | General VP | Profile | |
| Jodi Eddy | VP Officer | Profile | |
| Miriam Osullivan | Senior Officer | Profile | |
| Catherine Jennings | VP Interventions | Profile | |
| John Sorenson | Ex Operations | Profile | |
| Arthur Butcher | Executive Pacific | Profile | |
| Adam Smith | General Marketing | Profile | |
| Paudie OConnor | Executive Operations | Profile | |
| Vance Brown | Gen VP | Profile | |
| Joseph Fitzgerald | Executive Cardiology | Profile | |
| Daniel Brennan | Ex CFO | Profile | |
| Jeffrey Mirviss | Ex Interventions | Profile | |
| Susan Lisa | VP Relations | Profile | |
| Brenda Becker | Senior Affairs | Profile |
About Boston Scientific Management Performance
The success or failure of an entity such as Boston Scientific often depends on how effective the management is. Boston Scientific management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Boston management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Boston management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.16 | 0.16 | |
| Return On Capital Employed | 0.10 | 0.18 | |
| Return On Assets | 0.07 | 0.05 | |
| Return On Equity | 0.12 | 0.07 |
Boston Scientific Workforce Analysis
Traditionally, organizations such as Boston Scientific use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Boston Scientific within its industry.Boston Scientific Manpower Efficiency
Return on Boston Scientific Manpower
| Revenue Per Employee | 316K | |
| Revenue Per Executive | 985.1M | |
| Net Income Per Employee | 35K | |
| Net Income Per Executive | 109M | |
| Working Capital Per Employee | 9.8K | |
| Working Capital Per Executive | 30.6M |
Complementary Tools for Boston Stock analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |